Patent ID: 6562788
Filing Date: 2003-05-13
Classification: A61K,A61P,C07K,C12N,Y02A

Abstract:
A peptide having the following amino acid sequence:â€ƒâ€ƒâ€ƒâ€ƒThr-X1-Leu-Asp-Ile-X2-X3-Asp-Leu-X4-Glu-X5-â€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒ5â€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒ10 Arg-Leu-Lys-Tyr-Tyr-X6-X7-Arg-Lys-Glu-Phe-Leu-X8-â€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒ15â€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒ20â€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒâ€ƒ25 X9-X10-Leu-Gly(SEQ ID NO: 1) in which:X1=Gln or Glu X2=Leu or Lys X3=Arg or Lys X4=Phe or Tyr X5=Leu or Lys X6=Gly or Glu X7=Leu or Glu X8=Leu or Glu X9=Gln or Lys X10=Met or Nle, and the pharmaceutically acceptable protected derivatives thereof.